PU08.02 Low prevalence of likely depression among PrEP users in KenyaPublication OnlyDelivery technologies: novel approaches, formulation and multi-purpose
PU08.03 New in vitro release test methods for the dapivirine vaginal ringPublication OnlyDelivery technologies: novel approaches, formulation and multi-purpose
PU09.01 'If I knew about that, I wouldn't have stopped': increasing flexibility in PrEP use as a key to getting and keeping men on PrEPPublication OnlyDemand creation, market research, human-centred design
PU09.02 'PrEP makes HIV irrelevant': The effect of PrEP on reducing HIV stigmaPublication OnlyDemand creation, market research, human-centred design
PU11.01 Association between HIV infection and Diabetes Mellitus: a systematic review and meta-analysisPublication OnlyEpidemiology of HIV
PU11.02 Maraviroc less sensitive HIV-1 variants in a region where multiple non-B subtypes co-circulatePublication OnlyEpidemiology of HIV
PU14.01 Virological failure is consistent with acquired HIV drug resistance among adolescents living with perinatal HIV infection: evidence from the EDCTP-READY studyPublication OnlyHIV sequencing insights including viral diversity and antiretroviral resistance
PU14.02 Analysis of pre-ART MiSeq multiplexed longitudinal datasets demonstrated the env gene region as the most reliable for timing the entry of the virus into the reservoirPublication OnlyHIV sequencing insights including viral diversity and antiretroviral resistance
PU14.03 Increased frequency of inter-subtype HIV-1 recombinants identified by near full-length virus sequencing in a Rwanda acute heterosexual transmission cohortPublication OnlyHIV sequencing insights including viral diversity and antiretroviral resistance
PU14.04 Epidemiology and diversity of HIV-1 CRF37_cpx detected among ART-naive HIV-infected individuals in Rivers State, NigeriaPublication OnlyHIV sequencing insights including viral diversity and antiretroviral resistance
seek-warrow-warrow-eseek-e31 - 40 of 444 items